Skyrizi Pen coupons
Skyrizi Pen

Skyrizi Pen Coupons & Discount Card - Compare Prices Near You

Risankizumab is prescribed for the treatment of plaque psoriasis and psoriatic arthritis, as well as specific bowel diseases like Crohn's disease and ulcerative colitis. As a monoclonal antibody, it functions by inhibiting interleukin-23, a natural protein in the body that can lead to inflammation and swelling.
Our Skyrizi Pen coupons are free to use. You can print the coupon, email it to yourself, or receive the Skyrizi Pen coupon via text message. To get your free discount, show the pharmacist your Skyrizi Pen savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Skyrizi Pen prices will update based on your prescription needs. Above our Skyrizi Pen coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Skyrizi Pen savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.
Skyrizi Pen Side EffectsFAQs

My prescription

Edit

1ML of 150MG/ML, Skyrizi Pen (1 Pen)

Select pharmacy

Pharmacy logo

Rite Aid

$22301.23

COUPON PRICE
Pharmacy logo

Walgreens

$22329.82

COUPON PRICE
Pharmacy logo

Albertsons

$22572.07

COUPON PRICE
Pharmacy logo

Walmart

$23241.57

COUPON PRICE

Skyrizi Pen savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$22301.23

BIN

ID

PCN

GRP

015995

LHKDC554030

GDC

DR33

Powered by

This card is not insurance

Skyrizi Pen dosage forms

The average cost for 1 Pen of Skyrizi Pen at 1ML of 150MG/ML is $21523.55 with a free coupon. This is 27.27% off the average retail price of $78928.34
DosageQuantityPrice fromPer unit
1ML of 150MG/ML1 Pen$21523.55$21523.55

Skyrizi Pen Side Effects

Headache or tiredness may occur. If either of these effects lasts or gets worse, tell your doctor or pharmacist promptly. Remember that this medication has been prescribed because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. This medication may lower your ability to fight infections. This may make you more likely to get a serious infection or make any infection you have worse. Tell your doctor right away if you have any signs of infection (such as sore throat that doesn't go away, fever, chills). If you are using this medication to treat Crohn's disease or ulcerative colitis, risankizumab may rarely cause serious liver disease. Get medical help right away if you have any symptoms of liver damage, such as: nausea/vomiting that doesn't stop, loss of appetite, stomach/abdominal pain, yellowing eyes/skin, dark urine. A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Skyrizi Pen FAQs
What is a SKYRIZI pen?

The SKYRIZI pen is a pre-filled injection device used to administer the medication risankizumab, which is prescribed for the treatment of certain inflammatory conditions such as plaque psoriasis. The pen is designed for ease of use, allowing patients to self-administer the medication subcutaneously, typically under the guidance of a healthcare provider.

SKYRIZI is used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is also approved for the treatment of active psoriatic arthritis in adults.

SKYRIZI is not approved for the treatment of Crohn's disease. It is primarily used for plaque psoriasis and psoriatic arthritis. For Crohn's disease, other medications are typically prescribed, and the dosing schedule for SKYRIZI would not be applicable. It is important to consult a healthcare provider for appropriate treatment options for Crohn's disease.

SKYRIZI pen is used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is also used for the treatment of active psoriatic arthritis in adults.

Weight loss is not commonly reported as a side effect of SKYRIZI (risankizumab-rzaa). If a patient experiences unexpected weight changes while taking this medication, it is advisable to consult with a healthcare provider to determine the cause and appropriate action.

Related Drugs